Medication info
Glipiron M Tablets 2/500 milligrams

Glipiron M Tablets 2/500 milligrams

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/box [(10 tablets/PTP*3)]
Approval status
Active

MFDS item code 201106951 · Approved 2011.09.22 · Insurance code 649404510

Summary

Main use
Improves glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to effectively enhance blood sugar control in patients with type 2 diabetes alongside dietary and exercise therapy through the combined administration of Glymefide and Metformin.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medicine may pose a risk of severe lactic acidosis or hypoglycemia; thus, especially in cases of rapid decline in kidney function, discontinuation of the medication is necessary. It is important to temporarily discontinue this medication and consult a physician if there is dehydration or severe diarrhea, vomiting, or fever. Patients with a risk of cardiovascular disease should use this medication with caution as it may be associated with an increased rate of cardiovascular mortality. This medication should not be administered to patients with insulin-dependent diabetes, severe hepatic dysfunction, severely impaired kidney function, pregnant women, or nursing mothers. During the initial dosing, the risk of hypoglycemia is high; therefore, careful monitoring of meal status and blood sugar is required, especially in elderly patients or those with poor nutritional status, patients engaging in intense exercise, and those with high alcohol consumption. Common gastrointestinal side effects of this medication include gastrointestinal disorders, nausea, vomiting, diarrhea, but most of these are temporary and improve gradually. If serious allergic reactions or skin rashes develop, notify a physician immediately. Long-term use may result in vitamin B12 deficiency, necessitating regular blood tests. In patients with impaired kidney function, there is an increased risk of accumulation and lactic acidosis from this medication, so regular kidney function tests should be performed, and discontinuation should be considered if necessary. The combination with other medications may affect blood sugar control; therefore, any concurrent medications should be reported to healthcare providers. It is safer for women who are pregnant or planning to become pregnant, as well as nursing women, to avoid this medication. Overdose may cause hypoglycemia and lactic acidosis; immediate contact with a medical facility and appropriate treatment are required. Caution is necessary during driving or operating machinery due to the potential for hypoglycemia or other side effects. The safety and efficacy of this medication in children have not been established; thus, special care is needed when administering to children. During the intake of this medication, regular meals and exercise, along with routine monitoring of blood sugar and kidney function, are essential for managing therapeutic effects and side effects.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, indigestion, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disorder, erythema, pruritus, urticaria, rash, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, vitamin B12 deficiency, peripheral neuropathy, increased liver enzymes, liver function impairment, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, palpitations, dizziness, prostate enlargement, leg edema, cardiac arrest, rectal carcinoma, arthralgia, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to keep out air and moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.